Salagen

Salagen is a brand name of pilocarpine, approved by the FDA in the following formulation(s):

SALAGEN (pilocarpine hydrochloride - tablet; oral)

• 
  Manufacturer: EISAI INC
  
  Approval date: March 22, 1994
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: EISAI INC
  
  Approval date: April 18, 2003
  
  Strength(s): 7.5MG ^[RLD][AB]

Has a generic version of Salagen been approved?

Yes. The following products are equivalent to Salagen:

pilocarpine hydrochloride tablet; oral

• 
  Manufacturer: COREPHARMA
  
  Approval date: November 16, 2004
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: IMPAX LABS
  
  Approval date: March 31, 2006
  
  Strength(s): 5MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: LANNETT
  
  Approval date: October 14, 2005
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: LANNETT
  
  Approval date: May 6, 2009
  
  Strength(s): 7.5MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: December 22, 2004
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: February 27, 2007
  
  Strength(s): 7.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Salagen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Salagen.

See also...

• Salagen Consumer Information (Wolters Kluwer)
• Salagen Consumer Information (Cerner Multum)
• Salagen Advanced Consumer Information (Micromedex)
• Pilocarpine Consumer Information (Wolters Kluwer)
• Pilocarpine Consumer Information (Cerner Multum)
• Pilocarpine Advanced Consumer Information (Micromedex)